<Suppliers Price>

6-Methoxyindole

Names

[ CAS No. ]:
3189-13-7

[ Name ]:
6-Methoxyindole

[Synonym ]:
indole, 6-methoxy-
EINECS 221-689-6
6-methoxy-indole
5-Methoxyindole,~
6-MeO-indole
6-Methoxyindole
Methoxyindole
6-Methoxy-1H-indole
6-methoxylindole
MFCD00022780
1H-Indole, 6-methoxy-

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
297.8±13.0 °C at 760 mmHg

[ Melting Point ]:
90-92 °C(lit.)

[ Molecular Formula ]:
C9H9NO

[ Molecular Weight ]:
147.174

[ Flash Point ]:
109.2±10.1 °C

[ Exact Mass ]:
147.068420

[ PSA ]:
25.02000

[ LogP ]:
2.00

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.637

[ Storage condition ]:
Keep Cold

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2933990090

Precursor & DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.

J. Med. Chem. 54 , 5320, (2011)

Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance. IDO inhibition is thus an active...

Discovery of a novel class of PPARdelta partial agonists.

Bioorg. Med. Chem. Lett. 18 , 5018, (2008)

Anthranilic acid GW9371 was identified as a novel class of PPARdelta partial agonist through high-throughput screening. The design and synthesis of SAR analogues is described. GSK1115 and GSK7227 show...

Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach.

J. Med. Chem. 52 , 4941, (2009)

BPR0L075 (2) is a potential anticancer drug candidate designed from Combretastatin A-4 (1) based on the bioisosterism principle. Metabolites of 2, proposed from in vitro human microsome studies, were ...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.